Evidence map›Paper›PMID 23182396›Full record

ArticleInternational journal of radiation oncology, biology, physics2013

The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.

Kenneth B Roberts, Pamela R Soulos, Jeph Herrin, James B Yu, Jessica B Long, Edward Dostaler, Cary P Gross

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The impact of radiotherapy costs on clinical outcomes in breast cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2015
    Article
  17. Article
  18. The cost of cancer-related physician services to Medicare.The Yale journal of biology and medicine · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kenneth B RobertsCancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Comprehensive Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA.
Pamela R Soulos
Jeph Herrin
James B Yu
Jessica B Long
Edward Dostaler
Cary P Gross
Yale University · USYale Cancer Center · US

Funding

Use and Outcomes of Radiation Therapy for Medicare Patients with Common CancersR01CA149045 · NCI · YALE UNIVERSITY · PI GROSS, CARY P. · 2010 to 2012
$1.5M
NCI NIH HHS R01 CA149045NCI NIH HHS R01CA149045
6 · The paper itself

Abstract

purposeNew radiation therapy modalities have broadened treatment options for older women with breast cancer, but it is unclear how clinical factors, geographic region, and physician preference affect the choice of radiation therapy modality. METHODS AND MATERIALS: We used the Surveillance, Epidemiology, and End Results-Medicare database to identify women diagnosed with stage I-III breast cancer from 1998 to 2007 who underwent breast-conserving surgery. We assessed the temporal trends in, and costs of, the adoption of intensity modulated radiation therapy (IMRT) and brachytherapy. Using hierarchical logistic regression, we evaluated the relationship between the use of these new modalities and patient and regional characteristics.

resultsOf 35,060 patients, 69.9% received conventional external beam radiation therapy (EBRT). Although overall radiation therapy use remained constant, the use of IMRT increased from 0.0% to 12.6% from 1998 to 2007, and brachytherapy increased from 0.7% to 9.0%. The statistical variation in brachytherapy use attributable to the radiation oncologist and geographic region was 41.4% and 9.5%, respectively (for IMRT: 23.8% and 22.1%, respectively). Women undergoing treatment at a free-standing radiation facility were significantly more likely to receive IMRT than were women treated at a hospital-based facility (odds ratio for IMRT vs EBRT: 3.89 [95% confidence interval, 2.78-5.45]). No such association was seen for brachytherapy. The median radiation therapy cost per treated patient increased from $5389 in 2001 to $8539 in 2007.

conclusionsIMRT and brachytherapy use increased substantially from 1998 to 2007; overall, radiation therapy costs increased by more than 50%. Radiation oncologists played an important role in treatment choice for both types of radiation therapy, whereas geographic region played a bigger role in the use of IMRT than brachytherapy.

Indexed as

AgedAged, 80 and overAge FactorsBrachytherapyBreast NeoplasmsCosts and Cost AnalysisFemaleHumansInsurance, Health, ReimbursementMastectomy, SegmentalMedicareRadiotherapy, AdjuvantRadiotherapy, Intensity-ModulatedSEER ProgramSocioeconomic FactorsUnited States

Identifiers

PMID23182396
PMCPMC3606652
OpenAlexW2006530662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.